Published : 05 Oct 2012
Specialty Pharma company founded by an Ivy League university people today retained services of Aagami for finding a right CMO for their specific need of nanometer sized crystalline granules of very old molecule.
This company is developing proprietary prescription pharmaceuticals using drugs that are already on the market or active pharmaceutical ingredients that are generally recognized as safe. The company uses proprietary oral, controlled-release technologies, and intellectual property licensed from the top University.
It plans to seek approval from the U.S. Food and Drug Administration for its most advanced product candidate, as an anti-platelet therapy for the secondary prevention of stroke and acute cardiovascular events. For that they need a specific sized crystalline granules of a decades old molecule. They want to use Aagami network in India to connect to right CMO. Aagami in its qualifying research found several manufacturers in India that have great possibilities.